rs765903345
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The ENST00000373327.5(TRAF3IP1):c.463C>T(p.Arg155Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000889 in 1,461,818 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. R155R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000373327.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRAF3IP1 | NM_015650.4 | c.463C>T | p.Arg155Ter | stop_gained | 4/17 | ENST00000373327.5 | NP_056465.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRAF3IP1 | ENST00000373327.5 | c.463C>T | p.Arg155Ter | stop_gained | 4/17 | 1 | NM_015650.4 | ENSP00000362424 | ||
TRAF3IP1 | ENST00000391993.7 | c.463C>T | p.Arg155Ter | stop_gained | 4/15 | 1 | ENSP00000375851 | P1 | ||
TRAF3IP1 | ENST00000409739.2 | c.*332C>T | 3_prime_UTR_variant, NMD_transcript_variant | 4/5 | 3 | ENSP00000386648 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251308Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135862
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461818Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727206
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Senior-Loken syndrome 9 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 06, 2016 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 08, 2022 | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Experimental studies have shown that this premature translational stop signal affects TRAF3IP1 function (PMID: 26487268). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 254146). This premature translational stop signal has been observed in individual(s) with clinical features of Senior-Loken syndrome (PMID: 26487268). This variant is present in population databases (rs765903345, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Arg155*) in the TRAF3IP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TRAF3IP1 are known to be pathogenic (PMID: 21945076, 26487268, 29068549). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at